Articles Tagged With:
-
Injectable Implant Focus of HIV Treatment/ Prevention Research
Researchers with the University of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention are examining a new drug delivery system that uses dolutegravir, an established HIV drug, in a potential longacting treatment and prevention system. The system has been tested in animal models.
-
Research Strides May Offer Keys to Battling Gonorrhea
Researchers are investigating a rapid test that not only checks for gonorrhea infection, but also signals if a particular strain is antibiotic-resistant. On another front, scientists report that one dose of a developmental oral antibiotic proves effective in treating uncomplicated genital infections caused by gonorrhea.
-
Researchers Release Initial Results on Developmental Vaginal Ring
In an effort to provide both HIV/AIDS and unintended pregnancy protection, researchers have developed a vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel. Scientists have just released results of an initial clinical trial, noting no safety issues.
-
FDA Move Widens Approved Use of Human Papillomavirus Vaccine
The Food and Drug Administration has approved the use of the nine-valent human papillomavirus (HPV) vaccine in women and men ages 27-45. The Advisory Committee on Immunization Practices (ACIP) is scheduled to review further information at its February 2019 meeting, with a potential vote at that time. Insurance reimbursement often is based on ACIP guidance.
-
With Reclassification and New Name, Doors May Open for Internal Condom
The Food and Drug Administration has reclassified the female condom from a Class III device to a Class II device, putting it in the same category as the male condom.
-
New Year’s Resolutions for 2019
With a new year comes a time to set some goals to help your business succeed. Here are a few to get you started.
-
Finding Experienced OR Nurses Is a Challenge ASCs Should Tackle
ASCs may be at an advantage over hospital ORs when it comes to hiring nurses. For instance, the work hours in an ambulatory OR are more desirable. Still, both hospital and ASC OR settings will continue to see increasing shortages of nurses. ASCs will experience this problem because of their increasing case volume and rise in OR nursing demand.
-
Collaboration to Standardize Care and Quality Improvement in Joint Replacement
The Joint Commission (TJC) and the American Academy of Orthopaedic Surgeons (AAOS) have created a new collaboration for Total Hip and Knee Replacement (THKR) certification. AAOS brings clinical expertise to the collaboration while TJC contributes standards development and performance measurement requirements.
-
ASCs Continue Struggling With False Claims Act and Anti-Kickback Statute
Some ASCs shell out millions of dollars to settle False Claims Act or federal Anti-Kickback Statute violations. These often are the result of whistleblower reports and could have been caused by ASCs not conducting proper research before selling shares in the business. Other times, ASCs end up in compliance trouble often because leaders were not cautious when choosing tactics to improve their competitiveness in the healthcare marketplace.
-
Medicare’s 2019 Final ASC Payment Rule Includes Several ASCA Suggestions
The final ASC payment rule for 2019 provides some long-awaited improvements regarding how ASC payment rates are determined. Specifically, ASC payment rates now tie their rate increases to the same inflation rate that has been used for hospital outpatient departments.